Emerson announces acquisition of Bioproduction Group
by from on (#4DBX1)
Bio-G's scheduling and modeling systems combined with Emerson's life sciences technology and expertise portfolio will help companies bring therapies for cancer, diabetes and other illnesses to patients sooner.